Exposure to metal oxide nanoparticles administered at occupationally relevant doses induces pulmonary effects in mice. Issue 10 (25th November 2016)

• Record Type: Journal Article
• Authors: Présumé, Mirlande; Simon-Deckers, Angélique; Tomkiewicz-Raulet, Céline; Le Grand, Béatrice; Tran Van Nhieu, Jeanne; Beaune, Gregory; Duruphty, Olivier; Doucet, Jean; Coumoul, Xavier; Pairon, Jean-Claude; Boczkowski, Jorge; Lanone, Sophie; Andujar, Pascal
• Is Part Of: Nanotoxicology. Volume 10:Issue 10(2016)
• Page Start: 1535
• Page End: 1544
• Publication Date: 2016-11-25
• Subjects: Nanoparticles -- occupationally relevant dose -- pulmonary effect -- occupational exposure limit -- welding fume; Toxicology -- Periodicals; 615.9
• DOI: 10.1080/17435390.2016.1242797
• Languages: English
• ISSNs: 1743-5390

Abstract

Abstract: In spite of the great promises that the development of nanotechnologies can offer, concerns regarding potential adverse health effects of occupational exposure to nanoparticle (NP) is raised. We recently identified metal oxide NP in lung tissue sections of welders, located inside macrophages infiltrated in fibrous regions. This suggests a role of these NP in the lung alterations observed in welders. We therefore designed a study aimed to investigate the pulmonary effects, in mice, of repeated exposure to NP administered at occupationally relevant doses. We therefore chose four metal oxide NPs representative of those found in the welder's lungs: Fe2 O3, Fe3 O4, MnFe2 O4 and CrOOH. These NPs were administered weekly for up to 3 months at two different doses: 5 μg, chosen as occupationally relevant to welding activity, and 50 μg, chosen as occupationally relevant to the context of an NP-manufacturing facility. Our results show that 3 month-repeated exposures to 5 μg NP induced limited pulmonary effects, characterized by the development of a mild peribronchiolar fibrosis observed for MnFe2 O4 and CrOOH NP only. This fibrotic event was further extended in terms of intensity and localization after the repeated administration of 50 μg NP: all but Fe2 O3 NP induced the development of peribronchiolar, perivascular and alveolar fibrosis, together with an interstitial inflammation. Our data demonstrate for the first time a potential risk for respiratory health posed by repeated exposure to NP at occupationally relevant doses. Given these results, the development of occupational exposure limits (OELs) specifically dedicated to NP exposure might therefore be an important issue to address.